Self-driving vehicles and the cross-country drive


Following my post on cross-country driving, a reader asked me about this prospect but I suppose I am skeptical.

First, self-driving vehicles make it too easy to read a book or stare at your phone.  Driving yourself fixes your attention on what is unfolding before your eyes, and forces you to keep it there.  You might be bored for an hour, but you will catch periodic gems by always looking at the road before you and to the side.

Second, at least for a while self-driving vehicles will not be allowed to exceed speed limits.  Good luck with that.  A lot of America is marked at 25 mph when you can go 36 mph or maybe even 37 mph in a responsible manner.

Third, many of the best moments in cross-country driving come from the unexpected swerve — “hey, that looks interesting!”  And half of the time it is not.  Will the self-driving vehicle know when you might wish to swerve and pull over?

Fourth, there is something to be said for integrating the rhythms of your body with those of the car.  When you drive yourself, you feel the trip in a way the Waymo does not give you.  I would stress this point is a negative for most car trips, though perhaps not for a cross-country drive.  If you do not enjoy driving through the USA, maybe do not do the cross-country thing at all?  Walking through Paris or Istanbul remains a lovely alternative.

Automation and better AI might eventually solve or address some of those problems.  But the next available round of self-driving vehicles probably will not.




Source link

  • Related Posts

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    By Kevin Yao BEIJING, April 13 (Reuters) – China’s economy likely regained some momentum in the first quarter on solid exports, but growth is expected to cool over the rest…

    Epitopea Strengthens Scientific Advisory Board with Appointment of Leading Authority in Cancer, Lisa Butterfield

    CAMBRIDGE, United Kingdom and MONTREAL, April 13, 2026 (GLOBE NEWSWIRE) — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies for hard-to-treat solid tumors, today announced the appointment…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    As session returns, Eby's government faces 'peril' over DRIPA: political scientist

    As session returns, Eby's government faces 'peril' over DRIPA: political scientist

    Deep-fried food banned in new plans for school dinners

    Deep-fried food banned in new plans for school dinners

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    China poised for Q1 GDP growth rebound but Iran war dims 2026 outlook: Reuters poll

    What the ‘Real Housewives’ Think About Congress’s Reality TV Drama

    Metal Gear Solid movie finds new directors

    Metal Gear Solid movie finds new directors

    Cancer remains top cause of death in Canada as new study shows multiple types rising

    Cancer remains top cause of death in Canada as new study shows multiple types rising